| Model Number |
MCS-P3-29-AOA |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Aortic Valve Stenosis (1717)
|
| Date of Event |
01/27/2022
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that approximately 7 years and 5 months following the implant of this transcatheter bioprosthetic valve, the patient had shortness of breath and it was noted that there was aortic stenosis with a gradient of 39 mm hg, aortic valve area of.4 cm2, and a velocity of 4.2 m/s.The valve appeared to have been implanted deep.Subsequently a 23 mm non-medtronic valve was implanted.No additional adverse patient effects were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
Product analysis: no product was returned.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
Medtronic received information that approximately 7 years and 5 months following the implant of this transcatheter bioprosthetic valve, the patient had shortness of breath and it was noted that there was aortic stenosis with a gradient of 39 mm hg, aortic valve area of.4 cm2, and a velocity of 4.2 m/s.The valve appeared to have been implanted deep.Subsequently a 23 mm non-medtronic valve was implanted.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|